IL113967A - Piperazine derivatives pharmaceutical compositions containing them and their preparation - Google Patents

Piperazine derivatives pharmaceutical compositions containing them and their preparation

Info

Publication number
IL113967A
IL113967A IL11396795A IL11396795A IL113967A IL 113967 A IL113967 A IL 113967A IL 11396795 A IL11396795 A IL 11396795A IL 11396795 A IL11396795 A IL 11396795A IL 113967 A IL113967 A IL 113967A
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
piperazine derivatives
derivatives pharmaceutical
Prior art date
Application number
IL11396795A
Other languages
English (en)
Other versions
IL113967A0 (en
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Priority to IL12593695A priority Critical patent/IL125936A/xx
Publication of IL113967A0 publication Critical patent/IL113967A0/xx
Publication of IL113967A publication Critical patent/IL113967A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Hydrogenated Pyridines (AREA)
IL11396795A 1994-06-03 1995-06-01 Piperazine derivatives pharmaceutical compositions containing them and their preparation IL113967A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL12593695A IL125936A (en) 1994-06-03 1995-06-01 1-(4-indolyl)-4-¬2-(2-pyridylamino)ethyl¾ piperazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9411099A GB9411099D0 (en) 1994-06-03 1994-06-03 Piperazine derivatives

Publications (2)

Publication Number Publication Date
IL113967A0 IL113967A0 (en) 1995-10-31
IL113967A true IL113967A (en) 1999-03-12

Family

ID=10756114

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11396795A IL113967A (en) 1994-06-03 1995-06-01 Piperazine derivatives pharmaceutical compositions containing them and their preparation

Country Status (25)

Country Link
US (1) US5723464A (zh)
EP (1) EP0763031B1 (zh)
JP (1) JPH10500989A (zh)
KR (1) KR100359393B1 (zh)
CN (2) CN1048985C (zh)
AT (1) ATE192744T1 (zh)
AU (1) AU680147B2 (zh)
BR (1) BR9507910A (zh)
CA (1) CA2191871C (zh)
CZ (1) CZ287381B6 (zh)
DE (1) DE69516867T2 (zh)
DK (1) DK0763031T3 (zh)
ES (1) ES2145275T3 (zh)
FI (1) FI114985B (zh)
GB (1) GB9411099D0 (zh)
GR (1) GR3033449T3 (zh)
HU (1) HUT76466A (zh)
IL (1) IL113967A (zh)
MX (1) MX9605915A (zh)
NZ (2) NZ331452A (zh)
PT (1) PT763031E (zh)
RU (1) RU2165933C2 (zh)
SK (1) SK281418B6 (zh)
WO (1) WO1995033743A1 (zh)
ZA (1) ZA954525B (zh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
AU2622595A (en) * 1994-06-03 1996-01-04 John Wyeth & Brother Limited Novel processes and intermediates for the preparation of piperazine derivatives
EP0773942A1 (en) * 1994-07-26 1997-05-21 Pfizer Inc. 4-indole derivatives as serotonin agonists and antagonists
US5519025A (en) * 1995-04-10 1996-05-21 American Home Products Corporation 4-indolylpiperazinyl derivatives
US5486518A (en) * 1995-04-10 1996-01-23 American Home Products Corporation 4-indolylpiperazinyl derivatives
IT1282705B1 (it) * 1996-02-28 1998-03-31 Recordati Chem Pharm Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
US5990114A (en) * 1996-02-28 1999-11-23 Recordati, S.A., Chemical And Pharmaceutical Company Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence
DE19615232A1 (de) * 1996-04-18 1997-10-23 Merck Patent Gmbh Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten
DE19725664A1 (de) 1997-06-18 1998-12-24 Merck Patent Gmbh 3-Benzylpiperidine
US6399614B1 (en) 1997-08-01 2002-06-04 Recordati S.A. Chemical And Pharmaceutical Company 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring
AU9256498A (en) * 1997-08-01 1999-02-22 Recordati S.A. Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293807B1 (it) * 1997-08-01 1999-03-10 Recordati Chem Pharm Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico
US6271234B1 (en) 1997-08-01 2001-08-07 Recordati S.A., Chemical And Pharmaceutical Company 1,4-disubstituted piperazines
IT1293804B1 (it) 1997-08-01 1999-03-10 Recordati Chem Pharm Diarilalchilpiperazine attive sulle basse vie urinarie
US6376494B1 (en) 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
EP1087954A1 (en) * 1998-06-15 2001-04-04 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US20060287335A1 (en) 2000-11-28 2006-12-21 Wyeth Serotonergic agents for treating sexual dysfunction
US20060223824A1 (en) * 2000-11-28 2006-10-05 Wyeth Serotonergic agents
EP1367053A4 (en) * 2001-02-27 2005-08-03 Kaneka Corp PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE N-ARYL-1-AMINO-2-PROPANOL DERIVATIVES
US7091349B2 (en) 2002-03-12 2006-08-15 Wyeth Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
US7361773B2 (en) 2002-03-12 2008-04-22 Wyeth Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
IL163827A0 (en) * 2002-03-12 2005-12-18 Wyeth Corp Process for synthesizing chiral n-aryl piperazines
NZ535169A (en) 2002-03-12 2006-03-31 Wyeth Corp Process for making chiral 1,4-disubstituted piperazines
WO2003078396A1 (en) * 2002-03-12 2003-09-25 Wyeth Preparation of n1-(2’-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
US7179813B2 (en) 2003-06-11 2007-02-20 Wyeth Bicyclic indolyl derivatives and methods for their use as serotonergic agents
CN100436448C (zh) * 2003-06-11 2008-11-26 惠氏公司 二环吲哚基衍生物以及其作为5-羟色胺能活性剂的应用
TW200800959A (en) 2005-06-10 2008-01-01 Wyeth Corp Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor
WO2007146073A2 (en) * 2006-06-09 2007-12-21 Wyeth Method for enhancing cognitive function
BR112016028255A2 (pt) 2014-06-06 2017-08-22 Flexus Biosciences Inc agentes imunorreguladores
US11242319B2 (en) 2014-11-05 2022-02-08 Flexus Biosciences, Inc. Immunoregulatory agents
UY36390A (es) * 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
UY36391A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
IE65362B1 (en) * 1989-04-22 1995-10-18 Wyeth John & Brother Ltd Piperazine derivatives
GB9021535D0 (en) * 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
IL101722A (en) * 1991-05-02 1996-05-14 Wyeth John & Brother Ltd History of piperazine, their preparation and pharmaceutical preparations containing them
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
BR9507910A (pt) 1997-08-12
DE69516867T2 (de) 2000-11-02
EP0763031A1 (en) 1997-03-19
EP0763031B1 (en) 2000-05-10
US5723464A (en) 1998-03-03
IL113967A0 (en) 1995-10-31
PT763031E (pt) 2000-10-31
FI964815A (fi) 1996-12-02
AU2623095A (en) 1996-01-04
MX9605915A (es) 1997-12-31
FI964815A0 (fi) 1996-12-02
HU9603315D0 (en) 1997-01-28
RU2165933C2 (ru) 2001-04-27
DK0763031T3 (da) 2000-08-14
ZA954525B (en) 1996-12-02
NZ331452A (en) 2000-01-28
CA2191871A1 (en) 1995-12-14
KR100359393B1 (ko) 2003-01-24
ES2145275T3 (es) 2000-07-01
CN1048985C (zh) 2000-02-02
AU680147B2 (en) 1997-07-17
WO1995033743A1 (en) 1995-12-14
GB9411099D0 (en) 1994-07-27
FI114985B (fi) 2005-02-15
CZ350796A3 (en) 1997-06-11
NZ287498A (en) 1998-10-28
HUT76466A (en) 1997-09-29
CA2191871C (en) 2004-09-21
ATE192744T1 (de) 2000-05-15
DE69516867D1 (de) 2000-06-15
SK281418B6 (sk) 2001-03-12
JPH10500989A (ja) 1998-01-27
GR3033449T3 (en) 2000-09-29
CN1227841A (zh) 1999-09-08
SK154196A3 (en) 1997-08-06
CN1093122C (zh) 2002-10-23
CN1149873A (zh) 1997-05-14
KR970703333A (ko) 1997-07-03
CZ287381B6 (en) 2000-11-15

Similar Documents

Publication Publication Date Title
IL113967A (en) Piperazine derivatives pharmaceutical compositions containing them and their preparation
ES8707191A1 (es) Procedimiento para preparar analogos imidazolicos de mevalonolactona y derivados de los mismos
TW261616B (zh)
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
ES8605760A1 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo dietilaminoalcoxi sustituido y sus sales deadicion acidas y amonicas cuaternarias
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
TW252979B (zh)
IL108970A0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
EP1027051A4 (en) ANTITHROMBOTIC AGENTS
ES8802311A1 (es) Procedimiento de preparacion de derivados del triazol y de sus sales de adicion con los acidos apropiados
ZA935045B (en) Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives
ES8600203A1 (es) Procedimiento de preparacion de nuevos derivados aminoetoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias
EP0980366A4 (en) ANTITHROMOSIS

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees